When muscle mass and loading decrease, the stimulus to maintain bone strength may decrease as well
While GLP-1s are cost-effective for those with diabetes, for those with obesity, these medications are not cost-effective at current prices
in patients with T2DM (38) found that continuous GLP-1 administration via a subcutaneous pump to raise serum GLP-1 levels from a mean of 9.7 pM at baseline to 282 pM over 6 weeks significantly reduced plasma glucose concentrations, improved glycated hemoglobin, and enhanced insulin sensitivity and -cell function compared to placebo, with no significant limiting side effects reported
Ultimately, most people want a simple plan that fits the realities of midlifeone that takes into account a busy schedule, changes in appetite, and long-term health
Explore our co-located event, the Biosimilars & Innovator Biologics Summit, for more key developments
Anti-inflammatory effects of GLP-1 Beyond weight loss, GLP-1 medications directly combat joint inflammation
